(MAS) Masco - Overview
Stock: Faucets, Paint, Hardware, Plumbing, Coatings
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.86% |
| Yield on Cost 5y | 2.36% |
| Yield CAGR 5y | 10.06% |
| Payout Consistency | 55.3% |
| Payout Ratio | 39.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.5% |
| Relative Tail Risk | -7.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.10 |
| Alpha | -19.84 |
| Character TTM | |
|---|---|
| Beta | 0.970 |
| Beta Downside | 0.942 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.95% |
| CAGR/Max DD | 0.39 |
Description: MAS Masco January 02, 2026
Masco Corporation (NYSE:MAS) is a diversified manufacturer of home-improvement and building-product solutions operating across North America, Europe, and other international markets. Its two primary divisions are Plumbing Products-covering faucets, shower systems, PEX tubing, and related plumbing components-and Decorative Architectural Products, which supplies paints, primers, specialty coatings, hardware, and bathroom accessories under well-known brands such as DELTA, BRIZO, BEHR, and KILZ.
In fiscal 2023 the company generated roughly $9.4 billion in revenue, with the Plumbing Products segment contributing about 70 % of sales and delivering an operating margin near 13 %. Key economic drivers include U.S. housing-starts growth (which has averaged 1.2 % YoY in 2024), sustained DIY remodeling activity spurred by elevated home-equity withdrawals, and the ongoing shift toward water-efficient fixtures driven by tightening building codes. On the cost side, Masco continues to manage inflationary pressure on raw materials (copper, brass, resin) through long-term supply contracts and strategic sourcing.
Masco’s exposure to the broader building-products sector makes it sensitive to macro trends such as mortgage-rate movements and labor-market tightness, while its strong brand portfolio and private-label relationships provide pricing power in both professional-installer and consumer channels. For a deeper quantitative dive, the ValueRay platform offers granular metrics and scenario analysis that can help you assess MAS’s upside.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 827.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA -2.54 > 1.0 |
| NWC/Revenue: 18.20% < 20% (prev 17.09%; Δ 1.11% < -1%) |
| CFO/TA 0.19 > 3% & CFO 1.01b > Net Income 827.0m |
| Net Debt (2.61b) to EBITDA (1.27b): 2.06 < 3 |
| Current Ratio: 1.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (211.0m) vs 12m ago -3.21% < -2% |
| Gross Margin: 35.66% > 18% (prev 0.36%; Δ 3530 % > 0.5%) |
| Asset Turnover: 143.2% > 50% (prev 148.8%; Δ -5.58% > 0%) |
| Interest Coverage Ratio: 9.29 > 6 (EBITDA TTM 1.27b / Interest Expense TTM 101.0m) |
Altman Z'' 2.53
| A: 0.26 (Total Current Assets 2.96b - Total Current Liabilities 1.58b) / Total Assets 5.31b |
| B: -0.11 (Retained Earnings -576.0m / Total Assets 5.31b) |
| C: 0.18 (EBIT TTM 938.0m / Avg Total Assets 5.30b) |
| D: -0.01 (Book Value of Equity -77.0m / Total Liabilities 5.14b) |
| Altman-Z'' Score: 2.53 = A |
Beneish M -3.05
| DSRI: 1.06 (Receivables 1.18b/1.15b, Revenue 7.60b/7.88b) |
| GMI: 1.01 (GM 35.66% / 36.15%) |
| AQI: 0.96 (AQ_t 0.18 / AQ_t-1 0.18) |
| SGI: 0.96 (Revenue 7.60b / 7.88b) |
| TATA: -0.03 (NI 827.0m - CFO 1.01b) / TA 5.31b) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of MAS shares?
Over the past week, the price has changed by +10.26%, over one month by +10.36%, over three months by +17.93% and over the past year by -4.16%.
Is MAS a buy, sell or hold?
- StrongBuy: 6
- Buy: 4
- Hold: 13
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the MAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 74.5 | 2.2% |
| Analysts Target Price | 74.5 | 2.2% |
| ValueRay Target Price | 78.6 | 7.9% |
MAS Fundamental Data Overview February 03, 2026
P/E Forward = 15.748
P/S = 1.8346
P/B = 164.4201
P/EG = 1.5738
Revenue TTM = 7.60b USD
EBIT TTM = 938.0m USD
EBITDA TTM = 1.27b USD
Long Term Debt = 2.94b USD (from longTermDebt, last quarter)
Short Term Debt = 2.00m USD (from shortTermDebt, last quarter)
Debt = 3.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.61b USD (from netDebt column, last quarter)
Enterprise Value = 16.55b USD (13.94b + Debt 3.17b - CCE 559.0m)
Interest Coverage Ratio = 9.29 (Ebit TTM 938.0m / Interest Expense TTM 101.0m)
EV/FCF = 19.54x (Enterprise Value 16.55b / FCF TTM 847.0m)
FCF Yield = 5.12% (FCF TTM 847.0m / Enterprise Value 16.55b)
FCF Margin = 11.15% (FCF TTM 847.0m / Revenue TTM 7.60b)
Net Margin = 10.89% (Net Income TTM 827.0m / Revenue TTM 7.60b)
Gross Margin = 35.66% ((Revenue TTM 7.60b - Cost of Revenue TTM 4.89b) / Revenue TTM)
Gross Margin QoQ = 34.22% (prev 37.69%)
Tobins Q-Ratio = 3.12 (Enterprise Value 16.55b / Total Assets 5.31b)
Interest Expense / Debt = 0.79% (Interest Expense 25.0m / Debt 3.17b)
Taxrate = 27.54% (76.0m / 276.0m)
NOPAT = 679.7m (EBIT 938.0m * (1 - 27.54%))
Current Ratio = 1.88 (Total Current Assets 2.96b / Total Current Liabilities 1.58b)
Debt / Equity = -40.68 (negative equity) (Debt 3.17b / totalStockholderEquity, last quarter -78.0m)
Debt / EBITDA = 2.06 (Net Debt 2.61b / EBITDA 1.27b)
Debt / FCF = 3.09 (Net Debt 2.61b / FCF TTM 847.0m)
Total Stockholder Equity = -174.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.59% (Net Income 827.0m / Total Assets 5.31b)
RoE = -474.6% (negative equity) (Net Income TTM 827.0m / Total Stockholder Equity -174.2m)
RoCE = 33.85% (EBIT 938.0m / Capital Employed (Equity -174.2m + L.T.Debt 2.94b))
RoIC = 24.12% (NOPAT 679.7m / Invested Capital 2.82b)
WACC = 7.84% (E(13.94b)/V(17.11b) * Re(9.49%) + D(3.17b)/V(17.11b) * Rd(0.79%) * (1-Tc(0.28)))
Discount Rate = 9.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.95%
[DCF Debug] Terminal Value 79.60% ; FCFF base≈899.8m ; Y1≈959.4m ; Y5≈1.15b
Fair Price DCF = 87.27 (EV 20.74b - Net Debt 2.61b = Equity 18.12b / Shares 207.7m; r=7.84% [WACC]; 5y FCF grow 7.38% → 2.90% )
EPS Correlation: -28.78 | EPS CAGR: -47.11% | SUE: -4.0 | # QB: 0
Revenue Correlation: -59.89 | Revenue CAGR: -1.41% | SUE: -0.44 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.88 | Chg30d=-0.006 | Revisions Net=-2 | Analysts=20
EPS next Year (2026-12-31): EPS=4.19 | Chg30d=-0.022 | Revisions Net=-4 | Growth EPS=+6.6% | Growth Revenue=+2.8%